Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Features

Reexamining Misconceptions About β-Blockers in Patients With Diabetes

  1. Janet B. McGill, MD
    Clinical Diabetes 2009 Dec; 27(1): 36-46. https://doi.org/10.2337/diaclin.27.1.36
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • Tables
    • Figure 1.
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 1.

      Stages in the development of heart failure and recommended therapy by stage. EF, ejection fraction; HF, heart failure; FHx CM, family history of cardiomyopathy; LV, left ventricle; LVH, left ventricular hypertrophy. Reprinted with permission from Ref. 11. © 2005 American Heart Association.ACEI, ACE inhibitor

    • Figure 2.
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 2.

      Algorithm for the treatment of hypertension. BB, β-blocker; DBP, diastolic blood pressure; SBP, systolic blood pressure. Reprinted with permission from Ref. 6. © 2003 American Heart Association. ACEI, ACE inhibitor

    • Figure 3.
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 3.

      A1C at baseline and each maintenance month by treatment in the GEMINI trial, including the modified intention-to-treat population. The change from baseline to maintenance month 5 (primary outcome) was significant (mean difference [SD], 0.13% [0.05%]; 95% CI -0.22 to -0.04%; P = 0.004). Error bars indicate SD from mean. Reprinted with permission from Ref. 26. © 2004 American Medical Association

    • Figure 4.
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 4.

      Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive patients after 6 weeks of treatment. Values shown are ± SE. SBP inferences are based on an ad hoc analysis. *P ≤ 0.001 for dose-related trend tests for change from baseline in mean diastolic and systolic blood pressure for all carvedilol CR doses with placebo. DBP, diastolic blood pressure; SBP, systolic blood pressure. Reprinted with permission from Ref. 66.

    Tables

    • Figures
    • Table 1.

      Clinical Trial and Guideline Basis for Compelling Indications for Individual Drug Classes

      Table 1.
    • Table 2.

      AACE Evidence-Based Recommendations for Management of Hypertension and Concomitant Type 2 Diabetes

      Table 2.
    PreviousNext
    Back to top

    In this Issue

    December 2009, 27(1)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Clinical Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Reexamining Misconceptions About β-Blockers in Patients With Diabetes
    (Your Name) has forwarded a page to you from Clinical Diabetes
    (Your Name) thought you would like to see this page from the Clinical Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Reexamining Misconceptions About β-Blockers in Patients With Diabetes
    Janet B. McGill
    Clinical Diabetes Dec 2009, 27 (1) 36-46; DOI: 10.2337/diaclin.27.1.36

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Reexamining Misconceptions About β-Blockers in Patients With Diabetes
    Janet B. McGill
    Clinical Diabetes Dec 2009, 27 (1) 36-46; DOI: 10.2337/diaclin.27.1.36
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Treatment of Hypertension in People With Diabetes
      • Benefits of β-Blockers
      • Perceived Negative Metabolic Effects of β-Blockers
      • Common Misconceptions About Glycemic Control and Lipids
      • Common Misconceptions About Microalbuminuria
      • Common Misconceptions About Hypoglycemia
      • Common Misconceptions About Weight Gain
      • Adherence to Guideline-Recommended Medical Care
      • Role of β-Blockers in the Therapeutic Management of Patients With Comorbid Diabetes
      • Summary
      • Footnotes
      • REFERENCES
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?
    • The Role of the Kidney and Sodium-Glucose Cotransporter-2 Inhibition in Diabetes Management
    • Tests for Screening and Diagnosis of Type 2 Diabetes
    Show more Features

    Similar Articles

    Navigate

    • Current Issue
    • Papers in Press
    • Abridged Standards of Care
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.